Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT05677984

Awaken Prone Positioning Ventinlation in COVID-19 Patients

Conditions: COVID-19

Sex: All
Ages: 18 Years – 80 Years
Phase: NA
Enrollment: 470
Sponsor: Southeast University, China

Location: China

Summary

Awaken prone positioning (APP) ventilation has been widely accepted as a standard regimen in the management of COVID-19 patients. Physiological studies have proved ventilation/perfusion improvement during APP in COVID-19, which was associated improved oxygenation. However, the optimal duration for APP was not yet demonstrated. In this study, we aimed at the prolonged APP to see whether this could improve patients outcomes.

Eligibility Criteria

Inclusion Criteria:Aged > 18-yr to 85-yrSevere COVID-19 pneumonia (with typical radiographic alternations) and non-intubated patients.SpO2 <= 93% with ambient air at rest.PaO2/FiO2 <= 300 mmHgExclusion Criteria:Definite intolerance to APP (e.g. pregnancy, extremity deformity, recent fracture, open thoracic or abdomial surgery, pace-maker implant in recent 48-hr, spine stability, pelvis or facial fractures, predicted difficult airway)morbidity obesity, BMI > 40consciousness disorder (GCS < 13), delirium dementiahemodynamic instability (with norepinephrine > )NYHA Grade III or IVSevere hemoptysislong term home oxygenation of CPAPRefuse invasive mechanical ventilation (DNI DNR)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05677984). StuddyBuddy aggregates publicly available trial information.